Ustekinumab as Induction and Maintenance Therapy for Crohn’s DiseaseBrian G. Feagan, Paul Rutgeerts, Jewel Johanns et al.|New England Journal of Medicine|2016Cited by 1.8k
Effect of Maintenance Ustekinumab on Corticosteroid-Free Clinical Outcomes in Patients with Crohn’s DiseaseBrian G. Feagan, Subrata Ghosh, Christopher Gasink et al.|Gastroenterology|2017Cited by 3
Su1862 GUSELKUMAB IMPROVES SYMPTOMS OF FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 QUASAR INDUCTION STUDY RESULTS AT WEEK 12Axel Dignaß, Jessica R. Allegretti, Julián Panés et al.|Gastroenterology|2024Cited by 0